These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
486 related articles for article (PubMed ID: 25550115)
1. Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection. Zhang E; Lu M Med Microbiol Immunol; 2015 Feb; 204(1):11-20. PubMed ID: 25550115 [TBL] [Abstract][Full Text] [Related]
2. Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses. Ma Z; Zhang E; Yang D; Lu M Cell Mol Immunol; 2015 May; 12(3):273-82. PubMed ID: 25418467 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells. Wu J; Meng Z; Jiang M; Pei R; Trippler M; Broering R; Bucchi A; Sowa JP; Dittmer U; Yang D; Roggendorf M; Gerken G; Lu M; Schlaak JF Hepatology; 2009 Apr; 49(4):1132-40. PubMed ID: 19140219 [TBL] [Abstract][Full Text] [Related]
4. Control of hepatitis B virus replication by interferons and Toll-like receptor signaling pathways. Pei RJ; Chen XW; Lu MJ World J Gastroenterol; 2014 Sep; 20(33):11618-29. PubMed ID: 25206268 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis B Virus Does Not Interfere With Innate Immune Responses in the Human Liver. Suslov A; Boldanova T; Wang X; Wieland S; Heim MH Gastroenterology; 2018 May; 154(6):1778-1790. PubMed ID: 29408639 [TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice. Wu J; Lu M; Meng Z; Trippler M; Broering R; Szczeponek A; Krux F; Dittmer U; Roggendorf M; Gerken G; Schlaak JF Hepatology; 2007 Dec; 46(6):1769-78. PubMed ID: 17929296 [TBL] [Abstract][Full Text] [Related]
7. [Toll-like receptor dependent innate immune responses by primary mouse hepatocytes and its control of HBV replication]. Wu J; Chen MF; Xia YC; Guo Y; Lin Y; Sun C; Zhang CY; Chen Y; Liu SP; Hao YH; Lu MJ; Schlaak JF; Yang DL Zhonghua Gan Zang Bing Za Zhi; 2011 Nov; 19(11):838-42. PubMed ID: 22433306 [TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor-mediated innate immunity orchestrates adaptive immune responses in HBV infection. Du Y; Wu J; Liu J; Zheng X; Yang D; Lu M Front Immunol; 2022; 13():965018. PubMed ID: 35967443 [TBL] [Abstract][Full Text] [Related]
9. The innate immune response to hepatitis B virus infection: implications for pathogenesis and therapy. Chang J; Block TM; Guo JT Antiviral Res; 2012 Dec; 96(3):405-13. PubMed ID: 23072881 [TBL] [Abstract][Full Text] [Related]
10. Regulation of microRNA by hepatitis B virus infection and their possible association with control of innate immunity. Jiang X; Kanda T; Wu S; Nakamura M; Miyamura T; Nakamoto S; Banerjee A; Yokosuka O World J Gastroenterol; 2014 Jun; 20(23):7197-206. PubMed ID: 24966589 [TBL] [Abstract][Full Text] [Related]
12. Recent advances in different interactions between toll-like receptors and hepatitis B infection: a review. Soleiman-Meigooni S; Yarahmadi A; Kheirkhah AH; Afkhami H Front Immunol; 2024; 15():1363996. PubMed ID: 38545106 [TBL] [Abstract][Full Text] [Related]
13. Interaction between Hepatitis B Virus and Toll-Like Receptors: Current Status and Potential Therapeutic Use for Chronic Hepatitis B. Ma Z; Cao Q; Xiong Y; Zhang E; Lu M Vaccines (Basel); 2018 Jan; 6(1):. PubMed ID: 29337856 [TBL] [Abstract][Full Text] [Related]
14. Role of Toll-like receptor 2 in the immune response against hepadnaviral infection. Zhang X; Ma Z; Liu H; Liu J; Meng Z; Broering R; Yang D; Schlaak JF; Roggendorf M; Lu M J Hepatol; 2012 Sep; 57(3):522-8. PubMed ID: 22617154 [TBL] [Abstract][Full Text] [Related]
15. Interferon-β response is impaired by hepatitis B virus infection in Tupaia belangeri. Kayesh MEH; Ezzikouri S; Chi H; Sanada T; Yamamoto N; Kitab B; Haraguchi T; Matsuyama R; Nkogue CN; Hatai H; Miyoshi N; Murakami S; Tanaka Y; Takano JI; Shiogama Y; Yasutomi Y; Kohara M; Tsukiyama-Kohara K Virus Res; 2017 Jun; 237():47-57. PubMed ID: 28551415 [TBL] [Abstract][Full Text] [Related]
16. The IL-1R/TLR signaling pathway is essential for efficient CD8 Ma Z; Liu J; Wu W; Zhang E; Zhang X; Li Q; Zelinskyy G; Buer J; Dittmer U; Kirschning CJ; Lu M Cell Mol Immunol; 2017 Dec; 14(12):997-1008. PubMed ID: 28757610 [TBL] [Abstract][Full Text] [Related]
17. Hippo Pathway Counter-Regulates Innate Immunity in Hepatitis B Virus Infection. Luo X; Zhang R; Lu M; Liu S; Baba HA; Gerken G; Wedemeyer H; Broering R Front Immunol; 2021; 12():684424. PubMed ID: 34113355 [TBL] [Abstract][Full Text] [Related]
18. Toll-IL1 receptor-mediated innate immune responses vary across HBV genotype and predict treatment response to pegylated-IFN in HBeAg-positive CHB patients. Visvanathan K; Lang T; Ryan K; Wilson R; Skinner NA; Thompson AJ; Ahn SH; Weilert F; Abbott W; Gane E; Colledge D; Li K; Locarnini S; Mansell A; Revill PA J Viral Hepat; 2016 Mar; 23(3):170-9. PubMed ID: 26436722 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus genome replication triggers toll-like receptor 3-dependent interferon responses in the absence of hepatitis B surface antigen. Real CI; Lu M; Liu J; Huang X; Trippler M; Hossbach M; Deckert J; Jahn-Hofmann K; Ickenstein LM; John MJ; Gibbert K; Dittmer U; Vornlocher HP; Schirmbeck R; Gerken G; Schlaak JF; Broering R Sci Rep; 2016 Apr; 6():24865. PubMed ID: 27121087 [TBL] [Abstract][Full Text] [Related]
20. Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes. Lucifora J; Bonnin M; Aillot L; Fusil F; Maadadi S; Dimier L; Michelet M; Floriot O; Ollivier A; Rivoire M; Ait-Goughoulte M; Daffis S; Fletcher SP; Salvetti A; Cosset FL; Zoulim F; Durantel D Sci Rep; 2018 Mar; 8(1):5390. PubMed ID: 29599452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]